发明名称 Tacrolimus analogues, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same
摘要 The present invention relates to novel tacrolimus analogs, a composition for the prevention or treatment of neurological diseases or immune hypersensitivity disorders comprising the same, a method for preventing or treating neurological diseases or immune hypersensitivity disorders comprising administering the analogs to a subject, a method for preparing the analogs using an isolated modified Streptomyces sp. strain wherein the activity of one or more enzymes selected from the group consisting of TcsA, TcsB, TcsC and TcsD is reduced; and the isolated modified Streptomyces sp. strain for prepare the analogs.
申请公布号 US9505779(B2) 申请公布日期 2016.11.29
申请号 US201313774899 申请日期 2013.02.22
申请人 Intron Biotechnology, Inc. 发明人 Yoon Yeo Joon;Kim Jae Jong;Lim Si Kyu
分类号 C07D491/12;C12N9/10;A61K31/00;C07D493/16;C12P17/18;C07D498/18;C12N15/52 主分类号 C07D491/12
代理机构 McNees Wallace & Nurick LLC 代理人 McNees Wallace & Nurick LLC
主权项 1. A method for preparing a tacrolimus analogue which is substituted at position C21 of tacrolimus (Formula A), comprising: (a) culturing an isolated modified Streptomyces sp. strain in which the activity of one or more enzymes selected from the group consisting of endogenous TcsA, TcsB, TcsC and TcsD is reduced; and (b) feeding carboxylic acids to the strain, wherein the carboxylic acid is incorporated as an extender unit of C21 ally side chain of tacrolimus; the carboxylic acid in step (b) is trans-2-hexenoic acid or 4-methylpentanoic acid; and the tacrolimus analogue is 36,37-dihydro-37-methyl-FK506 or 36-methyl-FK506.
地址 Seongnam-Si, Gyeonggi-Do KR